MorphoSys AG (MOR)
17.91
-0.08
(-0.44%)
USD |
NASDAQ |
Apr 19, 12:43
MorphoSys Debt to Equity Ratio: 12.71 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.71 |
| September 30, 2023 | |
| June 30, 2023 | 7.615 |
| March 31, 2023 | 2.467 |
| December 31, 2022 | 4.144 |
| September 30, 2022 | |
| June 30, 2022 | -10.50 |
| March 31, 2022 | 2.020 |
| December 31, 2021 | 1.156 |
| September 30, 2021 | 0.4707 |
| June 30, 2021 | |
| March 31, 2021 | 0.4763 |
| December 31, 2020 | 0.4397 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.0001 |
| June 30, 2019 | 0.0002 |
| March 31, 2019 | 0.0002 |
| December 31, 2018 | 0.0001 |
| September 30, 2018 | 0.0001 |
| June 30, 2018 | 0.0002 |
| March 31, 2018 | 0.0003 |
| December 31, 2017 | 0.0002 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.0003 |
| June 30, 2017 | 0.0003 |
| March 31, 2017 | 0.0005 |
| December 31, 2016 | 0.0005 |
| September 30, 2016 | 0.0007 |
| June 30, 2016 | 0.0007 |
| March 31, 2016 | 0.0006 |
| December 31, 2015 | 0.0006 |
| September 30, 2015 | 0.0007 |
| June 30, 2015 | 0.0006 |
| March 31, 2015 | 0.0006 |
| December 31, 2014 | 0.0007 |
| September 30, 2014 | 0.0008 |
| June 30, 2014 | 0.0008 |
| March 31, 2014 | 0.0009 |
| December 31, 2013 | 0.0008 |
| September 30, 2013 | 0.0008 |
| June 30, 2013 | 0.0003 |
| March 31, 2013 | 0.0003 |
| December 31, 2012 | 0.0004 |
| September 30, 2012 | 0.0004 |
| June 30, 2012 | 0.0004 |
| March 31, 2012 | 0.0004 |
| December 31, 2011 | 0.0004 |
| September 30, 2011 | 0.0008 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-10.50
Minimum
Jun 2022
12.71
Maximum
Dec 2023
1.312
Average
0.4552
Median
Debt to Equity Ratio Benchmarks
| Incyte Corp | 0.00 |
| Novartis AG | 0.5254 |
| BioNTech SE | 0.0108 |
| Evaxion Biotech AS | -1.825 |
| Adaptimmune Therapeutics PLC | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.240B |
| Total Liabilities (Quarterly) | 2.186B |
| Shareholders Equity (Quarterly) | 54.22M |
| Current Ratio | 3.080 |
| Net Debt Paydown Yield | -9.26% |